BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and
distributor of dental lasers, announced today that its EPIC 10®
diode soft-tissue laser platform won the gold medal for Dental
Instruments, Equipment, and Supplies at the 15th Annual Medical
Design Excellence Awards ("MDEA"), the MedTech Industry's premier
design competition. The award was presented to BIOLASE® at the 2013
MDEA ceremony on Wednesday, June 19, in Philadelphia.
Sponsored by the Medical Device and Diagnostic Industry
("MD+DI") and organized by UBM Canon, the MDEA Program recognizes
the achievements of medical device manufacturers, their suppliers,
and the many people behind the scenes -- engineers, scientists,
designers, and clinicians -- who are responsible for the
groundbreaking innovations that are changing the face of healthcare
today. Each year a comprehensive evaluation of the entries is
performed by an impartial, multidisciplinary panel of third-party
jurors with expertise in biomedical engineering, clinical practice,
diagnostics, human factors, industrial design, manufacturing, and
medicine.
Federico Pignatelli, Chairman and CEO, said, "We are honored to
receive this recognition for our EPIC 10 diode laser system from
the best and brightest medical device designers in the world. This
award is the direct result of the dedication and passion of our
experienced engineers, designers and product managers and the
desire they have to deliver groundbreaking surgical tools that
provide better treatment solutions for dentists and their patients.
The EPIC 10 platform is FDA-cleared in dentistry and 19 medical
markets and represents the next generation of our diode laser
technology."
The U.S. Food and Drug Administration ("FDA") cleared the dental
EPIC 10 for a wide variety of dental applications on September 28,
2012. The EPIC 10S™, the medical version of the diode laser
platform, was cleared by the FDA on April 5, 2013, for use as a
surgical instrument for over 80 different indications in 19
additional medical markets including: ear, nose and throat, oral
surgery, arthroscopy, gastroenterology, orthopedics, general
surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology,
neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery,
thoracic surgery, urology, dermatology, aesthetics, and vascular
surgery. The veterinary version of the EPIC diode laser platform,
the V-Series™, was launched in February 2013.
"Winning this latest MDEA honor, the fourth resulting from our
collaboration with Morphix Design, is an affirmation of our
commitment to both the doctor and patient experience," said Dmitri
Boutoussov, Chief Technology Officer. "The MDEA sets the highest
standard for improving the delivery of medical products and
services and we are very pleased that the jurors recognized the
design of our EPIC platform for its versatility and for the
marriage of our advanced laser technology with ease of use for
improved patient outcomes."
BIOLASE's diode lasers are currently used in dentistry for a
wide variety of surgical soft-tissue procedures as an alternative
to invasive and traumatic conventional devices, such as the
high-speed drill, scalpel, or electrosurge. The 940nm laser
wavelength of the EPIC 10 platform is better absorbed by hemoglobin
(Hb) and oxyhemoglobin (HbO2) than other diode laser wavelengths,
so it cuts efficiently at low power and with considerably less heat
and discomfort, making it an excellent alternative to conventional
surgical devices. BIOLASE's EPIC 10 940nm wavelength diode laser
uses disposable tips which help reduce the risk of infection and
cross contamination and is also FDA cleared for tooth whitening and
temporary pain relief.
About the MDEA Program The 2013 Medical Design Excellence Awards
were presented by UBM Canon, the global advanced manufacturing and
MedTech authority, and by Medical Device and Diagnostic Industry
("MD+DI"), the industry's central source for late breaking news,
information, and business intelligence.
For more information about the MDEA, visit
www.MDEAwards.com, or e-mail mdea@ubm.com.
About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets innovative lasers in dentistry
and medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment and CAD/CAM intraoral scanners; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's proprietary laser products
incorporate over 350 patented and patent-pending technologies
designed to provide biologically clinically superior performance
with less pain and faster recovery times. Its imaginative products
provide cutting-edge technology at competitive prices to deliver
the best results for dentists and patients. BIOLASE's principal
products are revolutionary dental laser systems that perform a
broad range of dental procedures, including cosmetic and complex
surgical applications, and a full line of dental imaging equipment.
BIOLASE has sold more than 22,500 lasers. Other laser products
under development address ophthalmology and other medical and
consumer markets.
For updates and information on WaterLase® and laser dentistry,
find BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/biolaseinc and YouTube at
www.youtube.com/biolasevideos.
BIOLASE®, WaterLase®, EPIC 10®, EPIC 10S®, EPIC V-Series™, and
ComfortPulse™ are registered trademarks or trademarks of BIOLASE,
Inc.
Add to Digg Bookmark with del.icio.us Add to Newsvine
For further information, please contact: Michael Porter Porter,
LeVay & Rose, Inc. 212-564-4700
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Apr 2024 to May 2024
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From May 2023 to May 2024